Rising Amniotic Membrane Transplants is set to Propel the Growth of the Global Amniotic Membrane Market at a CAGR of 16.26%

Pune, India, September 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Amniotic Membrane Market.

Market Highlights

The Amniotic Membrane market is projected to reach USD 1.78 Billion by 2032 at 16.26% CAGR during the forecast period 2023-2032.

The cryopreservation amniotic membrane market segment is expected to lead the market and register a substantial CAGR to reach USD 1.78 Billion by the end of 2032. The rising number of ocular surgeries is expected to drive the market growth. However, the lyophilized amniotic membrane segment is projected to exhibit the highest CAGR of 16.26% from 2023 to 2032. The rising number of surgeries, increasing number of reconstruction procedures and cosmetic surgeries, and venous and pressure leg ulcers is driving the growth of the segment.

The Americas accounted for the largest market share of 37.4% in 2018, and the regional market is projected to register a CAGR of 11.75% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The India market is projected to exhibit the highest growth rate of 14.09% during the forecast period of 2019 to 2025. 

Segment Analysis

The global amniotic membrane market has been segmented on the basis of type, applications, end user and region. On the basis of type, the market has been divided into the cryopreserved amniotic membrane and lyophilized amniotic membrane. The cryopreserved amniotic membrane segment held the majority market share in 2018. However, lyophilized amniotic membrane is expected to be the fastest growing owing to the rising number of surgeries and an increasing number of reconstruction procedures & cosmetic surgeries.

Explore In-depth Details: Amniotic Membrane Market Research Report

Regional Analysis

Geographically, the global amniotic membrane market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for the amniotic membrane in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing prevalence of cicatricial pemphigoid and Stevens-Johnson syndrome; pterygium; persistent epithelial defects with ulceration; conjunctival surface reconstruction; and ocular surface reconstruction in patients with chemical and thermal burns in Europe are driving the growth of the amniotic membrane market in the region. Germany accounted for the largest market share of 25.3% in 2018, and the country-level market is projected to register a CAGR of 11.36% during the forecast period.

Key Industry Participants

Market Research Future (MRFR) recognizes Applied Biologics (US), Alliqua BioMedical, Inc. (US), Integra LifeSciences (US), Skye Biologics Inc. (California), MiMedx (US), Amniox Medical, Inc. (Florida), Katena Products, Inc. (US), Human Regenerative Technologies, LLC (US), Amnio Technology, LLC (US), and Osiris Therapeutics, Inc. (US) as the key players in the global amniotic membrane market.

Key Findings of the Study:

• The Global Amniotic Membrane Market is projected to reach over USD 1.69 Billion by 2030 at 4.3% CAGR during the review period of 2022 to 2030


• Americas accounted for the largest market share with North America being the major contributor to the growth of the market.


• The lyophilized amniotic membrane segment is projected to register the highest CAGR of 14.69% during the forecast period owing to the rising number of ocular surgeries.


• Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.